Pain pharmacogenetics

Pain is a significant problem in medicine. The use of PGx markers to personalize postoperative analgesia can increase its effectiveness and avoid undesirable reactions. This article describes the mechanisms of nociception and antinociception and shows the pathophysiological mechanisms of pain in the...

Full description

Saved in:
Bibliographic Details
Published inDrug metabolism and drug interactions Vol. 35; no. 3
Main Authors Slepukhina, Mariia A., Ivashchenko, Dmitriy V., Sheina, Maria A., Muradian, Andranik Alexandrovich, Blagovestnov, Dmitriy Alexeevich, Sychev, Dmitriy A.
Format Journal Article
LanguageEnglish
Published Germany De Gruyter 01.09.2020
Walter de Gruyter GmbH
Subjects
analgesics
anesthetics
Pain
pharmacogenetics
pain
analgesics
anesthetics
pharmacogenetics
Online AccessGet full text
ISSN0792-5077
2191-0162
2363-8915
DOI10.1515/dmpt-2020-2939

Cover

More Information
Summary:Pain is a significant problem in medicine. The use of PGx markers to personalize postoperative analgesia can increase its effectiveness and avoid undesirable reactions. This article describes the mechanisms of nociception and antinociception and shows the pathophysiological mechanisms of pain in the human body. The main subject of this article is pharmacogenetic approach to the selection of anesthetics. Current review presents data for local and general anesthetics, opioids, and non-steroidal anti-inflammatory drugs. None of the anesthetics currently has clinical guidelines for pharmacogenetic testing. This literature review summarizes the results of original research available, to date, and draws attention to this area.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:0792-5077
2191-0162
2363-8915
DOI:10.1515/dmpt-2020-2939